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Abstract 
Background: Malaria research is greatly dependent on and has drastically advanced with the possibility of geneti‑
cally modifying Plasmodium parasites. The commonly used transfection protocol by Janse and colleagues utilizes 
blood stage‑derived Plasmodium berghei schizonts that have been purified from a blood culture by density gradient 
centrifugation. Naturally, this transfection protocol depends on the availability of suitably infected mice, constituting 
a time‑based variable. In this study, the potential of transfecting liver stage‑derived merozoites was explored. In cell 
culture, upon merozoite development, infected cells detach from the neighbouring cells and can be easily harvested 
from the cell culture supernatant. This protocol offers robust experimental timing and temporal flexibility.
Methods: HeLa cells are infected with P. berghei sporozoites to obtain liver stage‑derived merozoites, which are 
harvested from the cell culture supernatant and are transfected using the Amaxa  Nucleofector® electroporation 
technology.
Results: Using this protocol, wild type P. berghei ANKA strain and marker‑free  PbmCherryHsp70‑expressing P. berghei 
parasites were successfully transfected with DNA constructs designed for integration via single‑ or double‑crossover 
homologous recombination.
Conclusion: An alternative protocol for Plasmodium transfection is hereby provided, which uses liver stage‑derived 
P. berghei merozoites for transfection. This protocol has the potential to substantially reduce the number of mice used 
per transfection, as well as to increase the temporal flexibility and robustness of performing transfections, if mos‑
quitoes are routinely present in the laboratory. Transfection of liver stage‑derived P. berghei parasites should enable 
generation of transgenic parasites within 8–18 days.
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Background
Genetic manipulation of Plasmodium parasites
In the past 15 years, Plasmodium parasites have become 
greatly accessible for genetic manipulation [1–3], facili-
tated by the genome sequencing of human and rodent 
malaria parasites [4–6]. Advances continue and Plas-
modium knowlesi parasites were recently successfully 
adapted for in  vitro culture in human red blood cells 
including successful transfection, which resulted in effi-
ciencies of up to 30% [7]. Transfection efficiencies of 
rodent Plasmodium berghei parasites have increased 
up to 1:1000 as a result of implementing the highly effi-
cient non-viral  Nucleofector® technology [1, 8]. A major 
advantage of using the model organism P. berghei for 
Plasmodium research is the accessibility of the entire life 
cycle in vitro as well as in vivo, including the liver stage 
development. A further advantage is the availability of an 
almost complete genomic DNA library that originated 
from phage-based vectors, applicable for generation of 
knock-outs, and tagging of genes [9–11]. Methods for 
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typical genetic manipulation, such as the generation of 
knock-outs and complemented parasites, fluorescent 
tagging of proteins and even conditional knock-outs, are 
available for both rodent and human Plasmodium para-
sites [9, 12–14]. Classically, transfection of DNA con-
structs into P. berghei parasites is performed into blood 
stage-derived schizonts and merozoites, and benefits 
from the fact that schizonts do not rupture in in  vitro 
blood cultures and can thus be enriched and purified. 
Transfection of schizonts and free merozoites, compared 
to other asexual blood stages, is facilitated by the fact 
that DNA used for transfection has to cross only two or 
three membranes, namely the erythrocyte membrane 
(depending on whether or not merozoites have been 
released), the parasite plasma membrane (PM) and the 
nuclear membrane, instead of four, including the parasi-
tophorous vacuole membrane [1]. The standard protocol 
for P. berghei transfection, requires the infection of two 
mice, which ideally should have a parasitaemia of about 
3% usually achieved between day 5 and 7 after pre-infec-
tion. Once the parasitaemia has reached about 3%, blood 
stage parasites are taken into culture for 16–18 h and fol-
lowing this, schizonts are purified using a density gradi-
ent. Purified schizonts and merozoites are subsequently 
transfected using the Amaxa  Nucleofector® electropora-
tion technology [1, 8]. This study took advantage of the 
fact that the merozoite stage of Plasmodium parasites 
is not restricted to the blood stage, but is also produced 
at the end of liver stage development. The Plasmodium 
liver stage is characterized by an immense expansion of 
the parasite population. Intriguingly, a single sporozo-
ite that has infected a host hepatocyte can mature into 
thousands of progeny merozoites [15]. At the end of 
exo-erythrocytic parasite development, merozoites are 
released from the parasitophorous vacuole (PV) into 
the hepatocyte cytoplasm. This leads to the detach-
ment of the infected host cell from its neighbouring cells 
and in in  vitro cultures, to detachment of the infected 
cells, which then float freely in the culture supernatant. 
Merosomes, sacs containing infectious merozoites, are 
subsequently extruded from the detached cell and are 
also found in the cell culture supernatant [16, 17]. Sin-
gle detached cells of in vitro-cultured P. berghei parasites 
were recently described to harbour an average of about 
4500 individual merozoites [16, 18]. In a previous study 
by Stanway et al. individual merosomes or detached cells 
were collected and used for sub-cloning of transgenic 
parasites, thereby greatly contributing to the reduction 
of animals used to achieve clonal transgenic parasite 
lines [17]. This work presents an established and opti-
mized protocol for transfection of liver stage-derived 
schizonts and merozoites, which equally aims to reduce 
the number of animals used for the generation of trans-
genic parasite lines.
Methods
Animal work statement
Experiments were conducted in strict accordance with 
the guidelines of the Swiss Tierschutzgesetz (TSchG; Ani-
mal Rights Laws) and approved by the ethical committee 
of the University of Bern (Permit Number: BE109/13). 
Balb/c mice used in experiments were between 6 and 
10 weeks of age and were either bred in the central ani-
mal facility of the University of Bern, or were supplied 
from Harlan Laboratories or Charles River.
Culturing of HeLa cells
HeLa cells (a gift from Robert Menard, Pasteur Institute, 
Paris) were grown in MEM (minimum essential medium) 
with Earle’s salts (Bioconcept, cat. no 1-31F01-I), supple-
mented with 10% heat inactivated foetal calf serum—FCS 
(Bioswisstec, Cat. No. S4150), 1% penicillin/streptomycin 
(Bioconcept, Cat. No. 4-01F00-H) and 1% l-glutamine 
(Bioconcept, 5-10K00-H) in a humid incubator with 5% 
 CO2 at 37  °C. Using accutase (Sigma-Aldrich, Cat. No. 
A6964), cells were passaged twice a week.
Infection of mosquitoes with Plasmodium berghei
A P. berghei blood stabilate was injected intraperitoneally 
into a naïve Balb/c mouse (referred to as ‘pre-infection 
mouse’). When this mouse had reached a parasitaemia of 
1–4%, 50  µl of infected blood, diluted with 150  µl PBS, 
were injected intravenously into a mouse (referred to as 
‘feed mouse’) that 3 days prior to that had been intraperi-
toneally injected with 200 µl phenylhydrazine (6 mg ml−1 
in PBS) (Sigma-Aldrich, Cat. No. 114715). When the feed 
mouse, had reached a parasitaemia of at least 7%, usually 
3–4 days after infection, with most of the circulating par-
asites being gametocytes, the mouse was anaesthetized 
and used to allow about 100–150 female Anopheles ste-
phensi mosquitoes to feed for 1  h. Infected mosquitoes 
were kept at 20.5  °C and 80% humidity and fed with 8% 
fructose containing 0.2% PABA (Sigma-Aldrich, Cat. No. 
100536). Infected mosquitoes were dissected to obtain 
sporozoites for the detached cell transfection protocol 
between day 16 and 24 post blood feed.
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In vitro infection of HeLa cells with Plasmodium berghei
Infection of HeLa cells with sporozoites required that 
mosquitoes infected with either P. berghei (ANKA strain) 
wild type parasites or any other selection-marker-free P. 
berghei parasite line were available.
On the day of the infection, the parasites in these mos-
quitoes were between day 16 to 24 post-blood feed. For 
one transfection (if more transfections were intended 
cells were seeded accordingly), HeLa cells were seeded 
into three wells of a 24-well plate (Greiner Bio-one, Cat. 
No. 662160) with 2 × 104 cells per well and cultured in 
complete MEM culture medium. On the following day 
at about 16.00, 3–5 infected mosquitoes per transfection 
were anesthetized with chloroform vapour. Anesthetized 
mosquitoes were briefly dipped into 70% (vol/vol) etha-
nol and then transferred to PBS.
For removal of salivary glands, mosquitoes were suc-
cessively put into 200 µl of infection medium [complete 
MEM culture medium containing 2.5  μg  ml−1 ampho-
tericin B (Sigma-Aldrich, Cat. No. A2942)] on a slide and 
the head was carefully removed using surgical forceps. 
The two sets of each three salivary gland lobes were iso-
lated from the head or mosquito body, and transferred 
into an Eppendorf tube containing 20  µl of infection 
medium, kept on ice until infection of HeLa cells. Sali-
vary glands were mechanically disrupted using a pestle 
(Sigma-Aldrich, Cat. No. Z359947) driven by a Cord-
less motor (Sigma-Aldrich, Cat. No. Z359971), using 
approximately 10 pulses of 1–2 s. Next, 300 µl of infec-
tion medium were added and the number of sporozoites 
was estimated using a Neubauer chamber.
Per anticipated transfection, 50,000 sporozoites were 
used, contained in a volume of 600 µl infection medium. 
After removing the medium from the three wells to 
be infected, 200  µl of sporozoite-containing infection 
medium were added to each of the three wells. To allow 
fast settling of the sporozoites, the 24-well plate was spun 
for 1  min at 200g. Following 2  h of incubation time (at 
37  °C with 5%  CO2), infected cells were washed with 
500  µl pre-warmed infection medium to remove mos-
quito debris and sporozoites that had not been infected. 
Cells were then incubated with 500 µl infection medium 
in a humid incubator at 37  °C with 5%  CO2. To avoid 
fungal and bacterial growth, the infection medium was 
exchanged at 24 and 48 h post infection (hpi).
Harvesting detached cells and merosomes
At about 62–65 hpi (about 09.00 at day 3 post-infec-
tion) it was verified by bright-field microscopy that 
detached cells/merosomes were present in the cell cul-
ture supernatant. Detached cells and merosomes are 
characterized by their round shape. They contain thou-
sands of small merozoites, which, in viable merosomes 
and detached cells, are constantly moving. If only few 
detached cells had been formed, infection duration 
was extended to up to 67 hpi. To harvest detached cells 
and merosomes, the supernatant of each well was gen-
tly pipetted up and down three times and finally the 
medium of the three infected wells was pooled into one 
Eppendorf tube. Parasites were pelleted at 16,000g for 
10 s, the direction of the tube was changed by 180° and 
the tube was spun again for 10 s at 16,000g. Successful 
centrifugation was verified by the presence of a small 
semi-transparent/white pellet visible at the bottom of 
the tube. If more than one transfection was planned, all 
sets of detached cells were prepared before the transfec-
tion was performed.
Transfection of liver stage‑derived merozoites
The transfection procedure was adapted from the pre-
viously published protocol by Janse et  al. [8]. Mice 
to be injected with transfected parasites were pre-
warmed using an infrared lamp for about 5–10  min 
prior to the injection, to allow the tail vein to dilate. 
5–10  µg of DNA (contained in a maximum volume of 
10 µl) were added to 100 µl Nucleofector solution 88A6 
(Lonza, Cat. No. VVPA-1002 KT) and the same was 
done for each of the constructs to be transfected. Next, 
using a 1000-µl pipette, the supernatant was carefully 
removed from one detached cell-containing Eppen-
dorf tube, without touching the detached cell pellet. 
Subsequently, 100  µl of DNA-containing Nucleofec-
tor solution 88A6 were added and the detached cells 
and merosomes were cautiously resuspended. Resus-
pended parasites were transferred from the Eppendorf 
tube into an electroporation cuvette and placed into 
the Amaxa Nucleofector device. Parasites were trans-
fected using the program U33 of the Amaxa Nucleo-
fector device. Immediately after transfection, 50  µl 
of RPMI1640 culture medium (Bioconcept, Cat. No. 
1-41F01-I) were added to the transfected parasites. 
Following this, the whole volume of the cuvette (about 
150  µl) was transferred into an Eppendorf tube using 
the provided Pasteur plastic pipette. Using an insulin 
syringe, the entire suspension was injected into the tail 
vein of a naïve Balb/c mouse (6–10  weeks of age) and 
the previous steps were repeated until all constructs 
were transfected.
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Drug selection and collection of transgenic parasites
One day after transfection, drugs suitable for selection of 
transgenic parasites were given to infected mice (depend-
ing on the transfected construct), as previously published 
[8]. Drug selection was continued until transgenic para-
sites had reached a parasitaemia of 2% or higher. From 
5  days after the transfection onwards, the parasitaemia 
of mice injected with transfected parasites was checked 
by thin blood smear. If the transfected construct encoded 
fluorescent or luminescent markers expressed under a 
promoter active in the blood stage, fluorescence or lumi-
nescence was also checked.
Detection of parasites by fluorescence
To stain the parasite DNA, a drop of blood from the 
infected mouse was added to 50  µl of PBS contain-
ing 1  μg  ml−1 Hoechst 33342 (Sigma-Aldrich, Cat. No. 
B2261) in PBS. Parasites were analysed under a fluores-
cence microscope using the appropriate filters and an 
increasing magnification of between 200× and 1000×.
Detection of parasites by luminescence (NanoLuc)
Parasite detection by luminescence was performed as 
described before [18]. Briefly, a drop of blood from the 
infected mouse was added to 20 µl of PLB (1 × Passive 
Lysis Buffer; Promega, Cat. No. E1941) contained in one 
well of a black, flat-bottom, 96-well plate (Greiner Bio-
One, Cat. No. 655900). As a negative control, blood was 
collected from a non-infected mouse. A 1:50 dilution of 
the NanoGlo substrate was prepared in  NanoGloTM lucif-
erase assay buffer (Promega, Cat. No. N1120), 50 µl of the 
dilution were added to the sample and the luminescence 
signal was read within 5 min.
Genotyping of transfected parasites
Genomic DNA of transfected parasites was purified. 
Integration PCR was performed according to the sche-
matic in Fig.  6. DNA sequences of primers used are 
shown in Table 1.
Results
This work presents an established protocol that allows 
efficient transfection of liver stage-derived merozoites in 
so-called detached cells and merosomes (Fig. 1). This pro-
tocol is based on the fact that in vitro, P. berghei-infected 
cells detach from their neighbouring cells and float into 
the cell culture supernatant. Thus, they can be easily puri-
fied by harvesting and then centrifuging the supernatant. 
After initially succeeding in transfecting detached cells/
merosomes, the next aim was to optimize the formation 
and yield of detached cells to quantify the corresponding 
number of merozoites used, and to standardize the pro-
tocol in a user-friendly way. As a first step, the optimal 
number of sporozoites to be used for host cell infection 
to maximize the generation of detached cells was deter-
mined (Fig.  2). As expected, with a constant number of 
host cells, the number of detached cells increases as the 
number of sporozoites used per infection increases. This 
increase is not linear and reaches a plateau with about 
50,000 sporozoites. On average, using 50,000 sporozoites, 
about 550 detached cells were obtained when harvesting 
at 65 hpi (Fig. 2a), which is about 20% of the parasites that 
were present at 48 hpi (Fig. 2b). When higher sporozoite 
numbers were used, the number of detached cells formed 
also increased but the conversion rate of parasites present 
at 48 hpi to detached cells dropped considerably (Fig. 2b), 
which suggests sub-optimal parasite development.
Having established the optimal sporozoite number to 
use for infection, the effect of age of the parasite in the 
mosquito on the number of detached cells/merosomes 
formed and the corresponding merozoite number was 
determined (Fig. 3a). Detached cell formation was quan-
tified, using sporozoites obtained from mosquitoes 
from day 16 to day 30 post-blood feed. Based on previ-
ous experiments, it was found that the success rate and 
efficiency of detached cell transfection starts to drop 
considerably when using fewer than 500 detached cells/
merosomes (4 × 106 merozoites). The minimum was set 
to 500 detached cells/merosomes and beyond day 24 post-
blood feed, numbers of detached cells formed dropped 
below this critical level. Accordingly, harvesting sporo-
zoites from mosquitoes between day 16 and day 24 post-
blood feed results in the sufficient formation of detached 
cells. Thus, sporozoites can be used over a period of nine 
consecutive days, during which transfections can be flex-
ibly and robustly planned and performed, as the processes 
from seeding of cells to liver stage-derived merozoite 
transfection takes place over a period of only 4 days.
For detached cell quantification, in addition to a fluo-
rescence microscopy-based assay, a luminescence-based 
assay was adapted to determine the numbers of detached 
cells and merozoites (Fig.  3). Using this assay, it was 
Table 1 Primers used for genotyping in Fig. 6
Primer Sequence (5′–3′)
1 GTGTAGTAACATCAGTTATTGTGTG
2 ATACTGTATAACAGGTAAGCTGTTATTGTG
3 TTTCCCAGTCACGACGTTG
4 CTTAGTGTTTTGTATTAATGTCGATT TG
QCR2 AGGGGCAAATACCAAAGTTGTGT
QCR1 ACGCATATTCACGAGTTTCACA
GW2 CTTTGGTGACAGATACTAC
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calculated that about 4.5–8.5 × 106 merozoites are used 
per transfection (Fig. 3a).
However, experiments also showed that not only the 
quantity but also the viability and quality of detached 
cells and contained merozoites is key to successful trans-
fection. Microscopic assessment is the fastest and most 
efficient way to assess detached cell morphology (Fig. 4). 
Transfection of detached cells had a better efficiency 
Day 0-3
In vitro infection of HeLa cells 
with P. berghei (a-c)
a
f
d
e
g h
c
b
i
k
j
l
Fig. 1 Workflow and visualization of critical protocol steps. a Optimal density of seeded HeLa cells 24 h post seeding. b Representative images of 
dissection of mosquito salivary glands (red arrow) attached to the head (left) or removed (right). c HeLa cells infected with P. berghei sporozoites at a 
density representing sporozoite numbers used in the here described protocol. d HeLa cells infected with  PbmCherryHsp70 65 hpi, prior to detached 
cell (red) collection. e Collection of detached cells at 65 hpi. f Representative image of collected  PbmCherryHsp70 detached cells (red) at 65 hpi and 
uninfected HeLa cell debris (unlabelled). g  Amaxa®  Nucleofector® II device with transfection program U33. h Intravenous injection of transfected 
parasites into a naïve mouse. i Drug selection of transgenic parasites. j Checking the parasitaemia by Wright stain or fluorescence. k Monitor trans‑
genic parasites by fluorescence. l Preparation of blood stabilates. Scale bars in all images are 50 µm
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when most of the detached cells contained viable and 
motile merozoites (Fig.  4a, b; Additional file  1: Movie 
S1) and only few abnormal detached cells were present 
(Fig.  4c, d). Furthermore, it is also important to micro-
scopically confirm that cells have not been contaminated 
during the process of infection with sporozoites, which 
Fig. 2 Experimental optimization of sporozoite numbers for HeLa cell infection to obtain maximal numbers of detached cells/merosomes. a, b 
HeLa cells were infected with different numbers of  PbmCherryHsp70 parasites and counted at 48 hpi. Detached cells and merosomes were counted 
in the supernatant at 65 hpi. a Total number of detached cells formed at 65 hpi depending on the number of sporozoites used for infection. b Per‑
centage of detached cells formed in relation to parasite count at 48 hpi was calculated. Shown are means with errors depicted as 95% confidence 
intervals, n = 3 in biological triplicates
Fig. 3 Microscopic and luminescence‑based determination of detached cell and merozoite number, dependent on the parasite age in infected 
mosquitoes. a The relation of the parasite age in infected mosquitoes to the number of detached cells obtained and the relative merozoite number 
was investigated from day 16 to day 30. A critical cut off (red line), in detached cell numbers obtained is at 500 detached cells (4 × 106 merozoites), 
as the success rate of detached cell transfections using fewer than 500 detached cells decreases. Seeding and infections were performed according 
to the present protocol, collected detached cells were counted using a fluorescent microscope at 65 hpi and merozoite number was determined 
using a luminescence based assay, n = 3. Error bars denote SD. b Determination of luminescence of detached cells obtained over time, using 
sporozoites from day 16 to day 30 post‑blood feed. Detached cells of  PbmCherryHsp70‑NLuc parasites were obtained and collected according to the 
present protocol. Aside from quantification of detached cell numbers by fluorescence, luminescence was used to estimate the number of detached 
cells used for transfection from day 16 onwards, following mosquito feeds. Luminescence correlates with number of detached cells contained, and 
suggests that at days 16–23, the number of viable merozoites remains relatively constant, while a significant decrease in luminescence is identified 
from day 24 onwards (denoting less detached cells and less merozoites). Values shown are the result of three independent experiments repeated 
in triplicate. Error bars denote SD. c  PbmCherryHsp70‑NLuc detached cells were collected and disrupted to release merozoites. The total number 
of merozoites of a single detached cell was counted, and a limiting dilution was performed to achieve one merozoite, which was lysed and its 
luminescence measured. The radiance calculated was 9.9 × 104 p s−1 cm−2. Performing a limiting dilution from 1 to  106 merozoites we defined that 
a positive, significant  (R2 = 0.96) correlation exists between merozoite number and the  log10 of the relative light units of luminescence. This in turn 
allowed us to estimate the total number of merozoites in single individual detached cells and of the complete population of detached cells used for 
transfection. Values shown are the result of ten separate limiting dilutions from three independent experiments
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can introduce bacteria and fungi, contained in the mos-
quito debris, to the cell culture (Fig. 3e). If contamination 
has occurred, transfection should not be performed, as 
contaminated detached cells must not be injected into 
mice.
This protocol was successfully used for transfection of 
DNA constructs facilitating integration into the parasite 
genome by single crossover homologous recombina-
tion (Figs. 5, 6; Table 2) to introduce DNA constructs for 
cytoplasmic GFP expression and expression of a lucif-
erase reporter gene in addition to a previously introduced 
cytoplasmic mCherry expression cassette [18]. Moreover, 
DNA constructs facilitating integration into the parasite 
genome by double crossover homologous recombina-
tion, were also successfully transfected, for example for 
the generation of knock-out and complemented parasites 
(Figs.  5, 6; Table  2). DNA constructs were successfully 
transfected into different parasite backgrounds, such 
as wild type parasites, selection-marker-free cytoplas-
mic mCherry expressing parasites [20] and knock-out 
parasites. In conclusion, all techniques used to transfect 
blood stage parasites can also be used to manipulate liver 
stage-derived merozoites.
Discussion
The protocol described here allows the generation of 
transgenic P. berghei parasites. If infected mosquitoes 
are routinely accessible, the protocol offers a flexible 
experimental procedure and the potential to reduce the 
number of mice used per transfection. In addition to 
transfection of P. berghei blood stages, the new protocol 
provides an optimized usage of P. berghei parasites for 
transfection. Using liver stage-derived merozoites for 
transfection, mouse numbers used should be reduced 
most efficiently when the protocol is used for high num-
bers of transfections. Transfection of liver stage-derived 
schizonts and merozoites of either wild type P. berghei 
ANKA or transgenic selection-marker-free P. berghei 
ANKA parasites has been proven successful for transfec-
tion of DNA constructs facilitating integration into the 
parasite genome by both single- and double-crossover 
homologous recombination. Transfections performed 
with DNA constructs for integration by single homolo-
gous recombination had a slightly higher success rate 
than transfections performed with DNA constructs that 
integrated by double crossover homologous recombina-
tion. Most likely this is related to the mechanism of inte-
gration and whether or not expression can be episomal, 
rather than being a consequence of the transfection pro-
cedure itself [23, 24].
Transfection of liver stage-derived detached cells and 
merosomes should be successful for all genetic modifica-
tions that can be achieved by single or double crossover 
homologous recombination, such as expression of pro-
teins fused with fluorescent, luminescent or other mark-
ers and interference with protein function by knock-out, 
Fig. 4 Representative microscopic images of detached cells. a Bright field and a′ fluorescence merged image of a normal detached cell, b and b′ 
of a ruptured detached cell and c, d examples of detached cells with abnormal morphology, c, c′ of merofusosomes [25] and d of absent merozoite 
formation. e Example of a fungal contamination of Plasmodium infected cells. Scale bars are 50 µm
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conditional knock-out, modification, over-expression or 
replacement. In addition, this protocol should also be suc-
cessful when introducing secondary genetic modifications 
such as complementation of previously knocked-out genes, 
additional marker fused proteins and double knock-outs.
A major advantage of the protocol is that liver stage-
derived merozoites can be collected and transfected in 
less than 20  min, which is time saving and presumably 
beneficial for parasite viability. This is mainly because 
mature detached cells/merosomes can be directly 
Fig. 5 Success rate of detached cell transfection of Plasmodium berghei parasites. Detached cells and merosomes of wild type or  PbmCherryHsp70 
parasites were transfected according to the present protocol. a Illustration of the total success rate of detached cell transfection independent of 
parasites used and constructs transfected. b Success rate of detached cell transfection using DNA constructs allowing integration via either single 
or c double crossover homologous recombination. d Example of successfully transfected  PbmCherryHsp70 parasites with a construct allowing 
expression of cytoplasmic GFP. Scale bar is 10 µm
Table 2 shows the individual detached cell transfections performed that  are summarized in  Fig.  5a–c with  informa-
tion about  the transfected construct, the parasite line that  was transfected, the type of  integration, the success rate, 
how often the transfection was performed and at which day after the transfection the mice became positive
Construct Parasite line Integration Success rate Number of  
transfections
Day mice 
became positive
PbSBP1KO (P0B90‑GFP) [19] mCherryHsp70 [20] Double crossover 50% (2) 2 7
PbSBP1KO (P0B90‑GFP) [19] mCherryHsp70FLucef1a [21] Double crossover 100% (1) 2 6
PbSBP1KO (P0B90‑GFP) [19] WT Double crossover 100% (1) 1 7
PfSBP1 (PL0017‑mCherry) [19] PbSBP1KO [19] Single crossover 100% (1) 1 8
PbGEM‑336027 mCherryHsp70 [20] Double crossover 100% (1) 1 21
PbNLuc (PL0017) [18] WT Single crossover 100% (1) 1 5
PbNLuc (PL0017) [18] mCherryHsp70 [20] Single crossover 100% (2) 2 4
PbNLuc (PL0017) [18] mCherryHsp70FLucef1a [21] Single crossover 66.6% (3) 3 4–5
PL0017 GFP [22] mCherryHsp70 [20] Single crossover 100% (8) 8 5–12
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WT d-ssu-rrna
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Single crossover integration
WT genome
KO genome
QCR2 QCR1
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990bp
hdhfr/yfcu
gDNA
Primers
PbWT PbKO
QCR2 + QCR1
PbWT PbKO
QCR2 + GW2
PCR: WT PCR: Integration
650bp
990bp
Double crossover integration
Fig. 6 Integration PCR of parasite lines generated by detached cell transfection using a single or b double crossover integration. a P. berghei 
parasites were transfected with pL0017‑NLuc [18], a construct that allows integration by single crossover into the P. berghei c‑ssu‑rRNA or d‑ssu‑rRNA 
locus. PCR amplification was used to verify integration of the plasmid into the P. berghei genome. The schematic shows the possible annealing 
regions of the primer pairs for the different parasite genotypes that could result. If the construct did not integrate into the parasite genome the 
primer pairs 1 + 4 for the c‑ssu‑rRNA or 2 + 4 for the d‑ssu‑rRNA locus generated a 3 kb PCR product. If the construct was successfully integrated, the 
primer pairs are too far apart (>14 kb) to generate a PCR product. Primer pairs 1 + 3 and 2 + 3 are designed to confirm integration, a PCR product 
of 3 kb is generated only if the construct has integrated. PCR results of the PbNLuc parasites show integration into the c‑ssu‑rRNA locus, as the band 
for primer pair 1 + 4 is absent and the primer pair 1 + 3 gives a 3 kb band, there is no integration into the d‑ssu‑rRNA locus, which shows the same 
PCR products as for the WT parasites. b P. berghei parasites were transfected with PbGEM‑336027, the construct facilitates integration of the hdhfr/
yfcu cassette via double crossover into the PBANKA_1145300 gene locus, resulting in a knock‑out (KO). The primer pair QCR2 + QCR1 results in a 
650 bp fragment, if parasites have a PBANKA_1145300 WT genotype. The primer pair QCR2 + GW2 is designed to show integration. A 990 bp PCR 
product is generated only, if the construct has integrated at the correct site of the parasite genome. The PCR results show integration of the hdhfr/
yfcu cassette into the PBANKA_1145300 gene locus. Transfected parasites are present in a mixed population of parasites having a PBANKA_1145300 
KO genotype and PBANKA_1145300 WT genotype
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collected from the cell culture supernatant and need no 
further purification by density gradient centrifugation as 
is needed for the purification of blood stage schizonts.
The standard protocol for blood stage transfection 
published by Janse et al. recommends using a minimum 
of  106 schizonts, corresponding to about 8–18  ×  106 
single merozoites per transfection [8]. Using the here-
described protocol for transfection of liver stage-derived 
merozoites, about 4.5–8.5  ×  106 merozoites are used 
per transfection, depending on the number of detached 
cells obtained. An important observation was that effi-
cient parasite development leading to the formation of 
detached cells is highly dependent on the age of parasites 
in infected mosquitoes. Therefore, it is recommended 
that mosquitoes are used between days 16 and 24 after 
blood feeding. Being able to use infected mosquitoes 
for 9 consecutive days to obtain detached cells, parasite 
transfections can be performed more flexibly in terms 
of timing and can be planned more robustly than is pos-
sible when performing blood stage transfections, which 
greatly depend on the parasitaemia of infected mice to 
be used for blood stage cultures. The liver stage develop-
ment in  vitro is independent of host circadian rhythms 
and accordingly, infections to obtain liver stage derived 
merozoites can be performed at any time of the day, 
offering flexible transfection conditions.
To obtain sporozoites needed for liver stage cultiva-
tion, a total of two mice is required: a pre-infection 
mouse in which infection is initially established from a 
blood stage stabilate of the parent P. berghei line, and a 
phenylhydrazine-treated recipient mouse (referred to 
as ‘feed mouse’), which will be infected with the donor’s 
blood, and thereafter used to feed the mosquitoes. Since 
only low blood volumes are passaged from the pre-infec-
tion mouse into the feed mouse, several feed mice can be 
infected from a single pre-infection mouse, to increase 
the number of mosquitoes that can be infected and thus 
the number of sporozoites that can be generated. In fact, 
in laboratories that routinely perform mouse infections 
with P. berghei, an additional pre-infection mouse is not 
required further reducing the number of experimental 
animals needed for the transfection.
During the optimization process of the protocol it was 
established that about 50,000 sporozoites are needed to 
obtain sufficient numbers of liver stage-derived merozo-
ites per transfection. On average this sporozoite number 
can be obtained from three infected mosquitoes [18]. 
Normally, about 100–120 mosquitoes are fed on a sin-
gle feed mouse. With a routine infection rate of about 
70–80%, about 80 infected mosquitoes were obtained. 
Per transfection, three mosquitoes that on average har-
bour about 50,000 sporozoites are dissected and used 
for the infection of HeLa cells. This infection results in 
about 500–1000 detached cells, which is sufficient for 
one transfection. Accordingly, it is possible to perform 
about 27 transfections with the number of infected mos-
quitoes that result from sacrificing a single feed mouse. 
Conversely, with the standard protocol used for transfec-
tion of blood stage-derived schizonts [8], which in theory 
requires 1 mouse per 4–5 transfections, performance of 
the same amount of transfections would require five mice.
Therefore, the protocol presented here is highly ben-
eficial when intending to perform transfections in large 
scale. Transfection of liver stage-derived merozoites and 
schizonts has the potential to reduce the mouse usage 
by about fivefold in laboratories that have routine access 
to infected mosquitoes compared to the current proto-
col based on blood stage transfection. Since the in vitro 
liver stage development of Plasmodium takes place in 
cell culture plates, it is very suitable for scaling up the 
experimental design. Potential critical points could be 
that sporozoites, following isolation, should be used suf-
ficiently quickly to ensure efficient host cell infection. 
Later in the experimental procedure, the time between 
detached cell purification and transfection is critical 
for parasite survival. Therefore, it is proposed that host 
cell infection with sporozoites and transfection of liver 
stage-derived parasites should be performed in sets, with 
a maximum of five transfections per set. Nevertheless, 
multiple infections could be prepared at time intervals if 
many transfections are planned.
Conclusions
So far, only one stage of Plasmodium berghei parasites, 
blood stage schizonts, could be transfected. Here a trans-
fection protocol is described using liver stage-derived 
merozoites of P. berghei, which can be generated in  vitro 
and in contrast to transfection of blood stage schizonts do 
not require sophisticated purification steps. The protocol 
described here provides more flexibility in terms of when 
and how many transfections can be performed. Moreo-
ver, transfection of liver stage-derived merozoites has 
the potential to result in a considerable reduction of mice 
used, if used by a lab that routinely has access to infected 
mosquitoes.
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